The mitigating effect of exogenous carbon monoxide on chronic allograft rejection and fibrosis post-lung transplantation

被引:1
|
作者
Aoki, Yoshiro [1 ,2 ]
Walker, Natalie M. [1 ,2 ]
Misumi, Keizo [1 ,2 ]
Mimura, Takeshi [1 ,2 ]
Vittal, Ragini [1 ,2 ]
McLinden, Aidan P. [1 ,2 ]
Fitzgerald, Linda [4 ]
Combs, Michael P. [1 ,2 ]
Lyu, Dennis [1 ,2 ]
Osterholzer, John J. [1 ,2 ,5 ]
Pinsky, David J. [3 ]
Lama, Vibha N. [1 ,2 ,6 ]
机构
[1] Univ Michigan Hlth Syst, Div Pulm, Ann Arbor, MI USA
[2] Univ Michigan Hlth Syst, Div Crit Care Med, Ann Arbor, MI USA
[3] Univ Michigan Hlth Syst, Div Cardiol, Dept Internal Med, Ann Arbor, MI USA
[4] Univ Michigan Hlth Syst, Dept Pharm Serv, Ann Arbor, MI USA
[5] VA Ann Arbor Hlth Syst, Pulm Sect, Ann Arbor, MI USA
[6] Univ Michigan Hlth Syst, Div Pulm & Crit Care Med, Dept Internal Med, 1500 W Med Ctr Dr,3916 Taubman Ctr, Ann Arbor, MI 48109 USA
关键词
cGMP signaling; carbon monoxide; sildenafil; lung transplant; mTOR signaling; MESENCHYMAL STEM-CELLS; BETA-CATENIN; ADULT LUNG; FIBROGENESIS; INHIBITION; EXPRESSION; PROTECTS; TARGET; DRIVEN; MODEL;
D O I
10.1016/j.healun.2022.11.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Small airway inflammation and fibrosis or bronchiolitis obliterans (BO) is the predomi-nant presentation of chronic lung allograft dysfunction (CLAD) post-lung transplantation. Carbon mon-oxide (CO) is a critical endogenous signaling transducer with known anti-inflammatory and anti -fibrotic effects but its therapeutic potential in CLAD remains to be fully elucidated. METHODS: Here we investigate the effect of inhaled CO in modulating chronic lung allograft rejection pathology in a murine orthotopic lung transplant model of BO (B6D2F1/J!DBA/2J). Additionally, the effects of CO on the activated phenotype of mesenchymal cells isolated from human lung transplant recipients with CLAD were studied. RESULTS: Murine lung allografts treated with CO (250 ppm pound 30 minutes twice daily from days 7 to 40 post -transplantation) demonstrated decreased immune cell infiltration, fibrosis, and airway obliteration by flow cytom-etry, trichrome staining, and morphometric analysis, respectively. Decreased total collagen, with levels compara-ble to isografts, was noted in CO-treated allografts by quantitative hydroxyproline assay. In vitro, CO (250 ppm pound 16h) was effective in reversing the fibrotic phenotype of human CLAD mesenchymal cells with decreased collagen I and b-catenin expression as well as an inhibitory effect on ERK1/2 MAPK, and mTORC1/ 2 signaling. Sildenafil, a phosphodiesterase 5 inhibitor, partially mimicked the effects of CO on CLAD mesen-chymal cells and was partially effective in decreasing collagen deposition in murine allografts, suggesting the contribution of cGMP-dependent and-independent mechanisms in mediating the effect of CO. CONCLUSION: These results suggest a potential role for CO in alleviating allograft fibrosis and mitigat-ing chronic rejection pathology post-lung transplant. J Heart Lung Transplant 2023;42:317-326 (c) 2022 International Society for Heart and Lung Transplantation. All rights reserved.
引用
收藏
页码:317 / 326
页数:10
相关论文
共 16 条
  • [11] Sirolimus to treat chronic and steroid-resistant allograft rejection-related fibrosis in pediatric liver transplantation
    Bernabeu, Jesus Quintero
    Goni, Javier Juamperez
    Hally, Maria Mercadal
    Fornieles, Crsitina Padros
    Lopez, Juan Ortega
    King, Mauricio Larrarte
    Gahete, Jose A. Molino
    Allende, Maria T. Salcedo
    Llompart, Ernest Hidalgo
    Aguirre, Itxarone Bilbao
    Torra, Ramon Charco
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2024, 79 (05) : 962 - 968
  • [12] Downregulation of a tumor suppressor gene LKB1 in lung transplantation as a biomarker for chronic murine lung allograft rejection
    Rahman, Mohammad
    Ravichandran, Ranjithkumar
    Sankpal, Narendra V.
    Bansal, Sandhya
    Sureshbabu, Angara
    Fleming, Timothy
    Perincheri, Sudhir
    Bharat, Ankit
    Smith, Michael A.
    Bremner, Ross M.
    Mohanakumar, T.
    CELLULAR IMMUNOLOGY, 2023, 386
  • [13] Molecular Profiling of Tissue Samples with Chronic Rejection from Patients with Chronic Lung Allograft Dysfunction: A Pilot Study in Cystic Fibrosis Patients
    Lunardi, Francesca
    Abbrescia, Daniela Isabel
    Vedovelli, Luca
    Pezzuto, Federica
    Fortarezza, Francesco
    Comacchio, Giovanni Maria
    Guzzardo, Vincenza
    Ferrigno, Pia
    Loy, Monica
    Giraudo, Chiara
    Fraia, Anna Sara
    Faccioli, Eleonora
    Braccioni, Fausto
    Cozzi, Emanuele
    Gregori, Dario
    Verleden, Geert M.
    Calabrese, Fiorella
    Schena, Francesco Paolo
    Rea, Federico
    BIOMOLECULES, 2023, 13 (01)
  • [14] A novel combined ex vivo and in vivo lentiviral interleukin-10 gene delivery strategy at the time of transplantation decreases chronic lung allograft rejection in mice
    Oishi, Hisashi
    Juvet, Stephen C.
    Martinu, Tereza
    Sato, Masaaki
    Medin, Jeffrey A.
    Liu, Mingyao
    Keshavjee, Shaf
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 156 (03) : 1305 - 1315
  • [15] Esophageal dysmotility according to Chicago classification v3.0 vs v2.0: Implications for association with reflux, bolus clearance, and allograft failure post-lung transplantation
    Tangaroonsanti, A.
    Vela, M. F.
    Crowell, M. D.
    DeVault, K. R.
    Houghton, L. A.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 30 (06)
  • [16] Effect of once-per-daytacrolimus versus twice-per-day ciclosporin on 3-year incidence of chronic lung allograft dysfunction after lung transplantation in Scandinavia (ScanCLAD): a multicentre randomised controlled trial
    Dellgren, Goeran
    Lund, Thomas Kromann
    Raivio, Peter
    Leuckfeld, Inga
    Svahn, Johan
    Holmberg, Erik C.
    Olsen, Peter Skov
    Halme, Maija
    Fiane, Arnt
    Lindstedt, Sandra
    Riise, Gerdt C.
    Magnusson, Jesper
    LANCET RESPIRATORY MEDICINE, 2024, 12 (01) : 34 - 44